SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027939
Filing Date
2016-11-07
Accepted
2016-11-07 16:06:21
Documents
44
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q fate-10q_20160930.htm 10-Q 1147665
2 EX-31.1 fate-ex311_7.htm EX-31.1 9826
3 EX-32.1 fate-ex321_9.htm EX-32.1 4812
  Complete submission text file 0001564590-16-027939.txt   4063989

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fate-20160930.xml EX-101.INS 732370
5 XBRL TAXONOMY EXTENSION SCHEMA fate-20160930.xsd EX-101.SCH 35398
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fate-20160930_cal.xml EX-101.CAL 39270
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fate-20160930_def.xml EX-101.DEF 126088
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20160930_lab.xml EX-101.LAB 297091
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20160930_pre.xml EX-101.PRE 217589
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-36076 | Film No.: 161978134
SIC: 2836 Biological Products, (No Diagnostic Substances)